Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin and biofeedback for recovery after meniscus repair
NCT05505747Phase 3Withdrawn
- Start
- Jul 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fisetin in Meniscus Tear (MT). Planned start Jul 2025; status: withdrawn.
02
Drugs
fisetin
03
Conditions
Meniscus Tear (MT)
Beyond the preview
Go deeper on NCT05505747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05505747.